Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;58(Suppl 2):7-11.
doi: 10.20471/acc.2019.58.s2.01.

PROSTATE CANCER DIAGNOSIS IN 2019 - CHANGES IN EUROPEAN GUIDELINES AND IMPACT ON DAILY PRACTICE

Affiliations
Review

PROSTATE CANCER DIAGNOSIS IN 2019 - CHANGES IN EUROPEAN GUIDELINES AND IMPACT ON DAILY PRACTICE

Igor Tomašković et al. Acta Clin Croat. 2019 Nov.

Abstract

Changes in the diagnostic pathway for prostate cancer advised in the most recent Guidelines of the European Association of Urology bring many endeavors for everyday practice. Availability, costs and radiological expertise are still representing a challenge for the adoption of these guidelines in everyday clinical practice. In this article we discuss the current situation regarding these issues and future options.

Keywords: Guidelines; Multiparametric Magnetic Resonance; Prostate Cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
shows availability of mp-MRI in 2019 across Croatia. White dots represent available mp-MRI, black dots unavailable mp-MRI of the prostate.

References

    1. Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87. 10.1016/j.ejca.2018.07.005 - DOI - PubMed
    1. Mottet N, van den Bergh RCN, Briers E, Cornford P, De Santis M, Fanti S, et al. EAU – ESTRO – ESUR – SIOG Guidelines on Prostate Cancer. https://uroweb.org/guideline/prostate-cancer. - PubMed
    1. Gandaglia G, Albers P, Abrahamsson PA, Briganti A, Catto JW, Chapple CR, et al. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019. Eur Urol. 2019;76(2):142–50. 10.1016/j.eururo.2019.04.033 - DOI - PubMed
    1. Stabile A, Giganti F, Rosenkrantz AB, Taneja SS, Villeirs G, Gill IS, et al. Multiparametric MRI for prostate cancer diagnosis: current status and future directions. Nat Rev Urol. 2020. July 17 - PubMed
    1. Ahmed HU, Kirkham A, Arya M, Illing R, Freeman A, Allen C, et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol. 2009;6(4):197–206. 10.1038/nrclinonc.2009.18 - DOI - PubMed

LinkOut - more resources